Spotlight
Jul 24
Featured Spotlight
Analysis of HIQA's Draft HTA on COVID-19 Vaccination for 2027/2028: Stakeholder Reactions and Policy Outlook
Analysis Briefing
Topics:
All Topics
Health Policy
HSE Services
Pharma & Science
Public Health
Workforce
rank:
all
hot
signal
- No posts yet.
- HIQA publishes draft health technology assessment of COVID-19 vaccination in Ireland (hiqa.ie) | 28d ago
- IPHA-HSE Framework Agreement on Medicine Pricing 2026-2029 (ipha.ie) | 146d ago
- NCPE Assessment: Belzutifan not cost-effective for VHL disease-associated tumours at current price (ncpe.ie) | 87d ago
- NIAC Issues Updated Standing COVID-19 Vaccination Recommendations for Ireland (May 2025) (hiqa.ie) | 65d ago
- NCPE Recommends Belzutifan (Welireg) Not Reimbursed for VHL Disease on Cost-Effectiveness Grounds (ncpe.ie) | 87d ago
- HIQA publishes health technology assessment on RSV immunisation in Ireland (hiqa.ie) | 90d ago
- NCPE Recommends Against Reimbursement of Belzutifan (Welireg) for von Hippel-Lindau Disease in Ireland (ncpe.ie) | 63d ago
- HIQA publishes 50 inspection reports on residential centres for older people in Ireland (hiqa.ie) | 7d ago
- HIQA Publishes Health Technology Assessment of RSV Immunisation in Ireland (hiqa.ie) | 90d ago
- FDA approves Guardant Health Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older (accessdata.fda.gov) | 731d ago
- FDA approves Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older (accessdata.fda.gov) | 920d ago
- HIQA Rapid Health Technology Assessment of RSV Immunisation for Infants and Older Adults in Ireland (hiqa.ie) | 713d ago
- HIQA Health Technology Assessment Recommends Shingles Vaccination for Older Adults in Ireland (hiqa.ie) | 738d ago
- HIQA publishes 20 inspection reports on designated disability centres (hiqa.ie) | 26d ago
- NIAC Updates RSV Vaccination Recommendations for Older Adults in Ireland (hiqa.ie) | 298d ago
- Analysis of Neoplasm Adverse Events Associated with GLP-1 Receptor Agonists from FAERS Database (frontiersin.org) | 63d ago
- GLP-1 Medications May Reduce Cancer Progression, Study Says (huffpost.com) | 64d ago
- Ireland to expand eligibility for state-funded IVF and assisted reproduction treatments from June 2025 (gov.ie) | 63d ago
- HIQA 2025 Annual Report details regulatory expansion, patient safety inspections, and health technology assessments in Ireland (hiqa.ie) | 208d ago
- HIQA publishes quarterly bulletin summarizing HTA and evidence synthesis work for April–June 2026 (hiqa.ie) | 27d ago
- Smart drug GRWD5769 shrinks lung cancer tumours by nearly 30% in patient trial (theguardian.com) | 56d ago
- Understanding Patient Safety Culture in Irish Healthcare – HIQA Patient Safety Conference 2024 (youtube.com) | 650d ago
- HIQA Publishes 22 Inspection Reports on Irish Disability Residential Centres (hiqa.ie) | 40d ago
- Reimbursement dispute over prostate cancer drug delays patient access (medicalindependent.ie) | 62d ago
- Electronic record keeping legislation enables digital prescription retention in Irish community pharmacies from June 2026 (ipu.ie) | 87d ago
- NIAC Spring 2025 COVID-19 Vaccine Recommendations (hiqa.ie) | 543d ago
- Dostarlimab (Jemperli) – NCPE Rapid Review Recommends Full HTA for Endometrial Cancer (ncpe.ie) | 67d ago
- HIQA finds insufficient evidence that shingles vaccine prevents dementia (imt.ie) | 65d ago
- Rapid Review of Rozanolixizumab (Rystiggo) for gMG Completed by NCPE (ncpe.ie) | 59d ago
- GLP-1 Receptor Agonists Associated with Reduced Metastatic Progression in Obesity-Related Cancers (ascopost.com) | 63d ago
- Oireachtas Briefing Paper on the Health (Assisted Human Reproduction) Amendment Bill (data.oireachtas.ie) | 102d ago
- Seanad Éireann Debate on NCPE Cost-Benefit Analysis (oireachtas.ie) | 172d ago
- Government Commits to Six-Month Deadline for Drug Reimbursement Decisions in Ireland (imt.ie) | 62d ago
- HIQA Inspection Report Finds Origins Foster Care Compliant with All Standards Assessed (hiqa.ie) | 38d ago
- Kerry mental health unit found 'high risk' in medication management and physical restraint practices (independent.ie) | 61d ago
- Phase 1 trial of ERAP1 inhibitor GRWD5769 shows tumor shrinkage in six cancer types when combined with cemiplimab (theguardian.com) | 52d ago
- Glucagon-like peptide 1 receptor agonists and cancer risk – systematic review (pmc.ncbi.nlm.nih.gov) | 63d ago
- Cost-Effectiveness Evidence on Approved Cancer Drugs in Ireland (pmc.ncbi.nlm.nih.gov) | 65d ago
- Minister for Health establishes Assisted Human Reproduction Regulatory Authority (gov.ie) | 64d ago
- HIQA: Evidence Insufficient to Recommend Shingles Vaccine for Dementia Prevention (independent.ie) | 65d ago
- HIQA: Single shingles vaccine's effect on dementia risk cannot be determined (irishtimes.com) | 65d ago
- HIQA Recommends Expanding BowelScreen to Ages 50-54; RSV Immunisation Cost-Effective Only with Lower Prices (hiqa.ie) | 87d ago
- New Irish legislation enables electronic record keeping in community pharmacies from June 2026 (ipu.ie) | 83d ago
- Not enough evidence to confirm shingles vaccination reduces dementia risk, says HIQA (irishexaminer.com) | 65d ago
- FDA Guidance on Post-Approval Studies for PMA Medical Devices (2022 Update) (fda.gov) | 1389d ago
- Oireachtas Debate on Medicinal Products Questions HSE Reimbursement (oireachtas.ie) | 146d ago
- HIQA publishes 50 inspection reports on residential centres for older people (hiqa.ie) | 59d ago
- HIQA Publishes Second HTA and Evidence Synthesis Bulletin for 2026 (hiqa.ie) | 25d ago
- HSE and NCPE Urged to Approve Reimbursement of Rare Disease Drug for Irish Patients (rte.ie) | 64d ago
- HIQA publishes inspections of Tusla children's residential centres in Ireland (hiqa.ie) | 81d ago
Showing page 1 of 2
(95 total results)
← Prev
Next →